Vivus, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360° view of the company.
Vivus, Inc. (Vivus or 'the company'), a subsidiary of Biopharma LLC, is a biopharmaceutical company focused on research, development, and commercialization of innovative and next-generation therapies which in turn addresses various medical needs of its patients. These products find application in cystic fibrosis, chronic pancreatitis, obesity, inflammatory bowel disease, and diabetes. Vivus's approved therapies include Qsymia and Pancreaze/Pancrease MT (pancrelipase). The company's pipeline product, Tacrolimus is being developed for the treatment of pulmonary arterial hypertension (PAH). Vivus markets its products under Qsymia and Pancreaze brand names. The company operations are spread across Australia, New Zealand, the US, and Rest of the World. The company is headquartered in Campbell, California, the US
Key Highlights
Vivus, Inc. (Vivus or 'the company'), a subsidiary of Biopharma LLC, is a biopharmaceutical company focused on research, development, and commercialization of innovative and next-generation therapies which in turn addresses various medical needs of its patients. These products find application in cystic fibrosis, chronic pancreatitis, obesity, inflammatory bowel disease, and diabetes. Vivus's approved therapies include Qsymia and Pancreaze/Pancrease MT (pancrelipase). The company's pipeline product, Tacrolimus is being developed for the treatment of pulmonary arterial hypertension (PAH). Vivus markets its products under Qsymia and Pancreaze brand names. The company operations are spread across Australia, New Zealand, the US, and Rest of the World. The company is headquartered in Campbell, California, the US
Scope
- Detailed information on Vivus, Inc required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Vivus, Inc in the form of a SWOT analysis
- An in-depth view of the business model of Vivus, Inc including a breakdown and examination of key business segments
- Intelligence on Vivus, Inc's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Vivus, Inc, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to Buy
- Gain understanding of Vivus, Inc and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Vivus, Inc as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Vivus, Inc's business structure, strategy and prospects.
Table of Contents
Company Snapshot
List of Tables
List of Figures